Advertisement
UK markets closed
  • FTSE 100

    8,213.49
    +41.34 (+0.51%)
     
  • FTSE 250

    20,164.54
    +112.21 (+0.56%)
     
  • AIM

    771.53
    +3.42 (+0.45%)
     
  • GBP/EUR

    1.1651
    -0.0032 (-0.27%)
     
  • GBP/USD

    1.2545
    +0.0012 (+0.10%)
     
  • Bitcoin GBP

    49,278.80
    +2,151.11 (+4.56%)
     
  • CMC Crypto 200

    1,331.60
    +54.62 (+4.28%)
     
  • S&P 500

    5,125.16
    +60.96 (+1.20%)
     
  • DOW

    38,672.31
    +446.65 (+1.17%)
     
  • CRUDE OIL

    78.39
    -0.56 (-0.71%)
     
  • GOLD FUTURES

    2,303.70
    -5.90 (-0.26%)
     
  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     
  • HANG SENG

    18,475.92
    +268.79 (+1.48%)
     
  • DAX

    18,001.60
    +105.10 (+0.59%)
     
  • CAC 40

    7,957.57
    +42.92 (+0.54%)
     

Zynex Sets First Quarter 2024 Earnings Call

ENGLEWOOD, Colo., April 18, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, will hold a conference call on Tuesday, April 30, 2024 at 4:15 PM Eastern Time to discuss its financial results for the first quarter ended March 31, 2024.  Financial results will be issued in a press release prior to the call.

Zynex
Zynex

Zynex management will host the conference call, followed by a question and answer session.

Date: Tuesday, April 30, 2024
Time: 4:15 PM Eastern Time (2:15 PM Mountain Time)
U.S. & Canada dial-in number: 800-836-8184
International number: 646-357-8785
Webcast: 1Q 2024 Webcast Link

ADVERTISEMENT

The Company will also provide a link at https://zynexmed.investorroom.com/ for those who wish to stream the call via webcast. Please call the conference telephone number 5-10 minutes prior to the start time.

About Zynex, Inc.

Zynex, founded in 1996, develops, manufactures, markets, and sells medical devices used for pain management and rehabilitation as well as non-invasive fluid, sepsis, and laser-based pulse oximetry monitoring systems for use in hospitals. For additional information, please visit: www.zynex.com.

Investor Relations Contact:
Quinn Callanan, CFA or Brian Prenoveau, CFA
MZ Group – MZ North America
ZYXI@mzgroup.us
+949 694 9594

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/zynex-sets-first-quarter-2024-earnings-call-302120512.html

SOURCE Zynex